Issue of Equity and total voting rights

By

Regulatory News | 08 Mar, 2023

Updated : 23:59

RNS Number : 3419S
Tekcapital plc
08 March 2023
 

 

 

8th March 2023

 

Tekcapital plc

 ("Tekcapital" or the "Company")

Issue of Equity and Total Voting Rights

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives has issued 100,000 ordinary shares of 0.4 pence in the Company at  a price of 17.25 pence per share, in consideration for the acquisition of numerous training and quality assurance materials for Tekcapital's Invention Evaluator service from Keon Research LLC ("Consideration Shares").

Application has been made for the 100,000 Consideration Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 14 March 2023. On Admission the Consideration Shares will rank pari passu with the existing ordinary shares, the total number of ordinary shares in issue with voting rights in the Company will be 164,854,828. There are no shares held in treasury. This figure may therefore be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

LEI: 213800GOJTOV19FIFZ85

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

For further information, please contact:

 

Tekcapital Plc 


Via Flagstaff IR

Clifford M. Gross, Ph.D. 






SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)


+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)






Flagstaff Strategic and Investor Communications

           

+44 (0) 20 7129 1474

Tim Thompson / Andrea Seymour / Fergus Mellon


 

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of   Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialise, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Tekcapital neither  intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSLFIAEDSEID

Last news